Price (delayed)
$7.06
Market cap
$215.07M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.16
Enterprise value
$36.54M
XBiotech is a fully integrated, global biopharmaceutical company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies. XBiotech currently is advancing a pipeline of therapies by harnessing naturally
Special dividends are included in TTM DPS and yield
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.